Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reactions and their management.

R Ganapati1, V V Pai

  • 1Bombay Leprosy Project, Mumbai 400022.

Journal of the Indian Medical Association
|May 6, 2005
PubMed
Summary
This summary is machine-generated.

Leprosy reactions, occurring in 20-30% of patients, include type-1 and type-2 episodes. These reactions manifest with skin issues and can lead to severe complications, necessitating risk identification and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Three drugs are unnecessary for treating paucibacillary leprosy-A critique of the WHO guidelines.

PLoS neglected tropical diseases·2019
Same author

Trial With Lepsulmin Ointment In Ulcers of Leprosy.

Indian journal of dermatology and venereology·2017
Same author

Absorption and Excretion of Dapsone in Leprosy Patients.

Indian journal of dermatology and venereology·2017
Same author

Effect of Prothionamide in Leprosy Clinico-bacteriological Observations.

Indian journal of dermatology, venereology and leprology·2017
Same author

Could ingenol mebutate be useful in managing nonmelanoma skin cancers?

Indian journal of cancer·2016
Same author

Hyperpigmented mycosis fungoides with ecthyma gangrenosum.

Indian journal of cancer·2016

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Immunology

Background:

  • Leprosy treatment can involve complex inflammatory episodes known as reactions.
  • These reactions, affecting 20-30% of patients, are broadly classified into type-1 (reversal) and type-2 (erythema nodosum leprosum).

Purpose of the Study:

  • To detail the clinical manifestations and sequelae of leprosy reactions.
  • To provide a guideline for identifying patients at risk of developing reactions.
  • To highlight current management strategies for leprosy reactions.

Main Methods:

  • Review of clinical presentations of type-1 and type-2 leprosy reactions.
  • Description of cutaneous and systemic manifestations.
  • Inclusion of sequelae such as deformities and renal damage.

Related Experiment Videos

  • Narrative of a guideline for risk-prone case identification.

    • Main Results:

    • Type-2 reactions in lepromatous leprosy (LL) and borderline lepromatous (BL) types present as erythema nodosum leprosum, erythema multiforme, and nodules.
    • Type-1 reactions occur in borderline and tuberculoid leprosy.
    • Manifestations include acute neuritis, arthritis, and edema; sequelae involve deformities and renal damage.

    Conclusions:

    • Leprosy reactions present diverse clinical features and potential long-term sequelae.
    • Identifying at-risk individuals is crucial for proactive management.
    • Prednisolone, following WHO guidelines, is a standard treatment in leprosy control programs.